FDA letter monthly archive

FDA Letters in November 2017

Name: FDA Letters in November 2017
Creator: Assyro AI
License: https://www.usa.gov/government-works

Browse FDA application-action, complete response, and warning letters issued or posted in November 2017. Each result links to a structured letter page with source-document access, metadata, and regulatory intelligence summaries.

CRLComplete Response Letter
Complete Response Letter Hospira, Inc. (Nov 3, 2017)
FDA's complete response letter contains source-text evidence related to Labeling, packaging, and proprietary name, Facility inspection and CGMP compliance. Theme counts identify where the letter discusses a topic; they do not replace review of the exact redacted letter.
IssuedNov 3, 2017
US FDA• BORTEZOMIB

Complete Response Letter Hospira, Inc. (Nov 3, 2017)